Diferencia entre revisiones de «Succinylcholine»

Sin resumen de edición
Sin resumen de edición
Línea 1: Línea 1:
== Contraindications ==
== Contraindications ==
#Known hyperK (current)
#Massive burns >10% BSA (>4dys-healed)
#Massive crush injuries (>4dys-healed)
#Denervation^ (>4dys-6mo)
#Neuromuscular dz^^ (indefinite)
#Intra-abdominal sepsis (>5dys-resolution)
#Increased ICP (may use w/ defacic dose)


(From-To)
{| style="width: 500px" border="1" cellpadding="1" cellspacing="1"
|-
| '''Contraindication<br/>'''
| '''From-To'''
|-
| Known hyperK
| current
|-
| Massive burns >10% BSA
| >4dys-healed
|-
| Massive crush injuries
| >4dys-healed
|-
| Denervation^
| >4dys-6mo
|-
| Neuromuscular dz^^
| indefinite
|-
| Intra-abdominal sepsis
| >5dys-resolution
|-
| Increased ICP
| may use w/ defacic dose
|}
 
^CVA (in particular those with residual deficits), spinal cord injury
^CVA (in particular those with residual deficits), spinal cord injury


Línea 23: Línea 42:
2/06 DONALDSON (Adapted from Rosen)
2/06 DONALDSON (Adapted from Rosen)


Levitan, R. Annals of EM. Vol 45, Issue 2. Safety of succinylcholine in myasthenia gravis.
Levitan, R. Annals of EM. Vol 45, Issue 2. Safety of succinylcholine in myasthenia gravis.<br/>


[[Category:Drugs]]
[[Category:Drugs]] <br/>[[Category:Airway/Resus]]
[[Category:Airway/Resus]]

Revisión del 04:53 13 mar 2011

Contraindications

Contraindication
From-To
Known hyperK current
Massive burns >10% BSA >4dys-healed
Massive crush injuries >4dys-healed
Denervation^ >4dys-6mo
Neuromuscular dz^^ indefinite
Intra-abdominal sepsis >5dys-resolution
Increased ICP may use w/ defacic dose

^CVA (in particular those with residual deficits), spinal cord injury

^^ALS, MS, skeletal muscle myopathies, cholinesterase def, h/o malignant hyperthermia

  • No evidence to support contraindication in penetrating eye injuries
  • N.B. Myasthenia Gravis- theoretically need more succ to induce vs nondepolarizing agents which have a prolonged effect.
  • This is 2/2 to lack of post-synaptic receptors, i.e. succ cannot potentiate a reaction 2/2 too few receptors.
  • Vs. it takes few "molecules" of roc/vec to block the few remaining functioning receptors.
  • Overall, most practitioners tend to avoid succ in all patients with possible neuromuscular disease.

Source

2/06 DONALDSON (Adapted from Rosen)

Levitan, R. Annals of EM. Vol 45, Issue 2. Safety of succinylcholine in myasthenia gravis.